Amyl Therapeutics bags €11m Series A extension

Amyl Therapeutics SA has secured €5m Series A extension from long-term investors Merieux Equity Partners and Noshaq, together with Mr Evren Ucok as a...

Mystery solved: Mysthera Theapeutics launches with $3.5m

Mysthera Therapeutics AG was just founded in Basel, Switzerland by Forty51 Ventures with $3.5m seed capital. Pursuing a first-in-class...

Pierre Fabre Laboratories collaborate with Vernalis

The French biotech company combines its experience in innovation, development, manufacturing, and commercialisation in oncology with the expertise of...

SpliceBio has made up a US $216m alliance with Spark Therapeutics

Under a globally exclusive licence option agreement with Roche AG, SpliceBio secures an upfront payment, opt-in and milestone payments up to $216m...

Study links TCM with effects on protein networks

The framework, validated with hospital patient data, is among the first to provide a scientific foundation to evaluate the therapeutic efficacy of...

AMR: Partnership set to improve in vivo antibiotics testing

The development of novel antibiotics is crucial in the fight against antimicrobial resistance (AMR) but has been neglected for decades due to a lack...

Synerkine Pharma BV secures EUR 12.1m in Series A extension

The Series A extension was led by Flerie with participation of existing investor Thuja Capital and new investors InnovationQuarter Capital and...